Insights

Innovative Drug Solutions Ncardia specializes in leveraging human iPSC technology for drug discovery, making it a valuable partner for biopharmaceutical companies seeking advanced cellular models for therapeutic development and screening.

Recent Product Launches The company's recent introduction of Ncyte NHP-C vCardiomyocytes and ready-to-use assays indicates ongoing innovation and product expansion, presenting opportunities to offer complementary solutions or technologies to enhance their offerings.

Strategic Collaborations Ncardia's partnerships with organizations like Kiniciti Bio highlight a pattern of collaborative growth, suggesting potential for joint ventures or co-developed products that could be mutually beneficial.

Strong Funding Support With over $60 million in funding and a revenue range of up to $10 million, Ncardia is positioned for scale and expansion, which could open doors for investment, supply chain solutions, or service partnerships.

Global Presence Operating across Europe and North America, Ncardia’s international footprint offers opportunities for sales and support services tailored to diverse biopharmaceutical markets and localized customer needs.

Similar companies to Ncardia

Ncardia Tech Stack

Ncardia uses 8 technology products and services including Matomo, Shopify, AMP, and more. Explore Ncardia's tech stack below.

  • Matomo
    Analytics
  • Shopify
    E-commerce
  • AMP
    Javascript Frameworks
  • OWL Carousel
    Javascript Libraries
  • Goober
    Javascript Libraries
  • Intercom
    Live Chat
  • UIKit
    UI Frameworks
  • Twitter
    Widgets

Media & News

Ncardia's Email Address Formats

Ncardia uses at least 1 format(s):
Ncardia Email FormatsExamplePercentage
First.Last@ncardia.comJohn.Doe@ncardia.com
88%
First.MiddleLast@ncardia.comJohn.MichaelDoe@ncardia.com
9%
FirLast@ncardia.comJohDoe@ncardia.com
2%
First@ncardia.comJohn@ncardia.com
1%

Frequently Asked Questions

Where is Ncardia's headquarters located?

Minus sign iconPlus sign icon
Ncardia's main headquarters is located at 8 Galileiweg Leiden, South Holland 2333 bd Netherlands. The company has employees across 2 continents, including EuropeNorth America.

What is Ncardia's official website and social media links?

Minus sign iconPlus sign icon
Ncardia's official website is ncardia.com and has social profiles on LinkedIn.

What is Ncardia's SIC code NAICS code?

Minus sign iconPlus sign icon
Ncardia's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Ncardia have currently?

Minus sign iconPlus sign icon
As of March 2026, Ncardia has approximately 44 employees across 2 continents, including EuropeNorth America. Key team members include CSO: H. B.Vice President Marketing: D. S.Divisional Ceo: J. D. G.. Explore Ncardia's employee directory with LeadIQ.

What industry does Ncardia belong to?

Minus sign iconPlus sign icon
Ncardia operates in the Biotechnology Research industry.

What technology does Ncardia use?

Minus sign iconPlus sign icon
Ncardia's tech stack includes MatomoShopifyAMPOWL CarouselGooberIntercomUIKitTwitter.

What is Ncardia's email format?

Minus sign iconPlus sign icon
Ncardia's email format typically follows the pattern of First.Last@ncardia.com. Find more Ncardia email formats with LeadIQ.

How much funding has Ncardia raised to date?

Minus sign iconPlus sign icon
As of March 2026, Ncardia has raised $60M in funding. .

When was Ncardia founded?

Minus sign iconPlus sign icon
Ncardia was founded in 2011.

Ncardia

Biotechnology ResearchSouth Holland, Netherlands11-50 Employees

Ncardia is a drug discovery company and expert in human iPSC technology. We operate worldwide with facilities, offices and staff throughout Europe and North America. We work with biopharmaceutical companies in drug discovery worldwide, to leverage the power of stem cell technologies in the development of novel therapies of multiple modalities at any stage of development. 

Over the past 10 years, we have built the expertise and infrastructure required to differentiate, manufacture and characterize high-quality iPSC-derived cell and disease models. We can facilitate the process of disease modeling and high-throughput screening to accelerate drug discovery.
We listen to our customer’s project plans, questions and challenges, and co-develop human iPSC-based solutions that fit their specifications.

Explore our website to learn more www.ncardia.com.

Section iconCompany Overview

Headquarters
8 Galileiweg Leiden, South Holland 2333 bd Netherlands
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2011
Employees
11-50

Section iconFunding & Financials

  • $60M

    Ncardia has raised a total of $60M of funding over 1 rounds. .

  • $1M$10M

    Ncardia's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $60M

    Ncardia has raised a total of $60M of funding over 1 rounds. .

  • $1M$10M

    Ncardia's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.